|
High-dose Methotrexate (8 gm/m2; HD-MTX) Clinical Trials
1 actively recruiting trial across 1 location
No change since May 2026
Pipeline
Phase 2: 1
Top Sponsors
- Wake Forest University Health Sciences1
Indications
- Leptomeningeal Disease1
- Metastatic Breast Cancer1
- Breast Cancer1
- Cancer1
Baltimore, Maryland1 trial
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Sidney Kimmel Comprehensive Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.